Volume Spike Investor

These are this morning’s top day trader and active trader alert stocks seen on the move with news events.  We have provided appropriate trading data and color on each where applicable.
QUALCOMM Corp. (NASDAQ: QCOM) has done something to try to halt what has been a share price freefall after 7 straight down days.  The CDMA [...]

Dendreon Corporation (NASDAQ: DNDN) is trading lower after pricing its 15 million shares secondary offering last night.  The price went off at a deeper discount than the trading activity had hinted at because the price was $24.75 versus a $25.65 close.  The stock had been around $26.50 to $27.00 before the offering was announced this [...]

Dendreon Corp. (NASDAQ: DNDN) is down after the company said it was raising cash.  It is selling 15 million shares of common stock through JPMorgan and Deutsche Bank.  This traded 198,000 shares last night in the after-hours and the stock fell 1.84% to $26.15 after a $26.64 close.  Volume is actually very thin this morning.  [...]

Dendreon Corp. (NASDAQ: DNDN) is trading higher on word from the company that it has filed its new drug application with the FDA for PROVENGE to treat prostate cancer.  The notion of the filing is not new, although many were not expecting this filing to be submitted until later in November or in December.  At [...]

Dendreon Corporation (NASDAQ: DNDN) is surging on news that the company has added two new directors to its board.  These are Ian Clark, the CEO of Roche’s Genentech unit, and Pedro Granadillo, a former Eli Lilly (LLY) manufacturing executive.  These are viewed as top brass to help the company transition from pre-revenue into a revenue [...]

Dendreon Corp. (NASDAQ: (DNDN) is playing give-back this morning after buyout rumors or hopes were running that stock yesterday.  At 8:44 AM EST we have seen over 180,000 shares trade hands and shares are down 3% at $26.56. This traded 14 million shares yesterday and was the highest closing level since the return of the [...]

Dendreon Corp. (NASDAQ: DNDN) is surging on exponential volume today as traders are speculating, and hoping, that the company will become a takeover target.  The word today is over hopes of a “European drug/bio/ buyer”.  At 2:05 PM EST we have shares up almost 12% at $26.69 and volume is exponential at 8.8 million shares [...]

Dendreon (Nasdaq: DNDN) shares are among the market’s most active in the premarket as of 9 a.m. Eastern, up more than 5 percent with nearly 80,000 shares traded, following a price target increase at a boutique research firm.
Meriman reiterated a Buy rating and raised its target on Dendreon to the $49 to $50 range, up [...]

Dendreon (DNDN) shares are trading about 4% lower on a sudden surge in volume as of about 10 a.m. Eastern this morning.
Market participants appear to be questioning if the timing of a plant buildout laid out in a filing late yesterday means that the company’s Provenge drug could be delayed.  — Mike Tarsala
For details, go [...]

Dendreon Corp. (NASDAQ: DNDN) is seeing a gap-up this morning after Citigroup started coverage of the prostate cancer PROVENGE owner with a BUY rating and a $35 price target.  Shares closed at $25.61 yesterday, and at 8:17 AM EST we have seen 35,000 shares trade hands.  The last price is $26.45.  As a reminder, the [...]